Ruokun Wang is a board-certified toxicologist and experienced drug developer, currently serving as Senior Director of Toxicology at Eli Lilly and Company. Previously, Ruokun held various roles in nonclinical safety at leading pharmaceutical companies, including Biogen, Ironwood Pharmaceuticals, and Roche. With a strong background in safety evaluations and regulatory submissions, Ruokun has contributed to drug development programs from discovery through post-marketing. Ruokun earned a PhD in Pharmacology and Physiology from Rutgers University and is a Diplomate of the American Board of Toxicology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices